EverSweet is due to be launched in 2018 following the recent, much-awaited collaboration agreement with Cargill. Evolva is due to participate in the JV at the 30% level, and will also benefit from a new state-of-the-art bioprocessing facility for its other products. Our fair value is CHF0.81 per share and we believe the current share price offers a good entry point.

Continue reading

This version is programmatically created by Research Central and qualified in its entirety to the original PDF.

Powered by Research Central